Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Scinai Immunotherapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate for 31 Dec 2024.
Scinai Immunotherapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2024 was $384,000.
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.